[PSTX] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[PSTX] Poseida Therapeutics, Inc.
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -15.74%
YoY- -145.13%
Quarter Report
PSTX's Result
PSTX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 25,973 28,142 24,995 9,352 20,013 10,343 9,921 90.06%
PBT -31,371 -24,274 -25,349 -31,671 -27,456 -38,847 -33,026 -3.37%
Tax 0 1,337 -6,040 -107 4,681 1,359 292 -
NP -31,371 -24,274 -23,990 -31,778 -27,456 -40,206 -33,318 -3.93%
Tax Rate - - - - - - - -
Total Cost 57,344 52,416 48,985 41,130 47,469 50,549 43,239 20.73%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -120.78 -86.26 -95.98 -339.80 -137.19 -388.73 -335.85 -49.46%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.32 -0.25 -0.27 -0.35 -0.32 -0.47 -0.39 -12.36%
EPS Diluted -0.32 -0.25 -0.27 -0.35 -0.32 -0.47 -0.39 -12.36%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.